PATENT CLAIM ANALYSIS

Application Number: 15880628
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["544", "376000"]

Abstract:
The present invention relates to compounds for the treatment of chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis. The present invention further relates to drug delivery devices suitable to be used in the treatment of chronic obstructive airway diseases such as a nebulizer comprising the present compounds. Specifically, the present invention relates to (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone or N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide or a pharmaceutically acceptable salt or base thereof for use in the treatment of chronic obstructive airway diseases, preferably chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis, more preferably chronic obstructive pulmonary disease (COPD).

Claim (Index 17):
The method of treating a chronic obstructive airway disease in a subject according to  claim 1 , wherein said chronic obstructive airway disease is asthma.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 2.32
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15318635', '15880634', '15576290', '14654046', '15560170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8206177302302169
- 35 USC 102 Novelty (BERT): 0.6900181592344555
- Combined Prediction Score: 0.8075577731306408
- Mean Citation Score: 490.02409000000006
- Max Citation Score: 731.21295
- Similarity Product: 700.4589049704551

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test